Skip to main content
. Author manuscript; available in PMC: 2012 Jul 6.
Published in final edited form as: Nutr Cancer. 2009;61(2):238–244. doi: 10.1080/01635580802404196

TABLE 1.

Genistein and complement 3 concentrations in serum and nipple aspirate fluid (NAF) before and after isoflavone interventiona

20 mg Isoflavones
70 mg Isoflavones
Before After Δ Before After Δ
Serum genistein (ng/ml)
 Mean 17.3 (12) 172.8 (12) 155.5 (12) 26.3 (15) 620.5 (15) 594.3 (15)
 SD 16.7 85.0 92.5 48.2 360.6 367.3
 Median 15.8 171.1 143.6 14.8 528.5 507.3
Serum C3 (ng/ml)
 Mean 24,138 (14) 23,252 (14) −886 (14) 18,432 (17) 16,157 (17) −2,275 (17)
 SD 13,395 12,478 6,843 12,512 12,837 15,594
 Median 27,673 17,828 446 14,191 12,040 −1,925
NAF C3 (ng/mg)b
 Mean 0.37 (9) 0.15 (9) −0.23 (9) 0.35 (14) 0.51 (14) 0.16 (14)
 SD 0.37 0.15 .43 0.44 0.95 0.81
 Median 0.23 0.070 −0.03 0.14 0.12 −0.00
NAF C3 (ng/ml)
 Mean 49.6 (9) 20.5 (9) −29.1 (9) 48.4 (14) 62.2 (14) 13.8 (14)
 SD 65.1 30.4 77.5 70.7 152.9 113.5
 Median 17.6 15.5 −4.3 23.4 13.1 −0.4
a

The values were obtained as follows: The change (Δ) that occurred in each individual (after treatment — before treatment) was calculated. Then the mean, SD, and median values for the changes were calculated. Change in serum genistein was significant for both the low- and high-dose isoflavones groups (P < 0.01 for both). Change in serum C3, NAF C3 (ng/ml), and NAF C3 (ng/mg) were not significant for either dosage group. Numbers in parentheses represent subjects with matched before and after treatment samples.

b

ng/mg: ng C3 per mg total NAF protein.